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INTRODUCTION
The use of nutritional and dietary supplements by athletes is   
a standard practice in sports at all levels. Several published reports 
on supplementation in professional sport show high intake of multiple 
products by some athletes at the same time [1,3,22,28-30].   
This occurs although the use of nutritional supplements seems 
unnecessary when athletes use a well-balanced diet. In addition, many 
studies do not confirm the ergogenic or anabolic effects of numerous 
products, which are advertised by their manufacturers as performance 
enhancing [2,4,8,11,24]. Apart from the biomedical side effects of 
some supplements used by consumers on their health [10,12], athletes 
need to be aware that taking these products can cause positive results 
in doping control [5,6,13]. A failed doping test resulting from the 
intake of a supplement can originate from the athlete’s poor knowledge 
of banned substances indicated on  the label, from the fact that the 
labelled ingredients indeed contain banned substances or that the 
supplement contains a banned substance not indicated or concealed 
on the label [14,15,18,19,21,31]. One should also take into consideration 
the fact that the list of substances and methods prohibited in sport, 
published annually by  the World Anti-Doping Agency (the WADA 
Prohibited List), has an open character. In spite of the examples of 
prohibited substances or methods in particular groups, some additional 
substances, which are not present on the list, but are characterized 
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by “a similar chemical structure or similar biological effect(s)”, can be 
considered as doping. This was the case for example with 4-methyl-
2-hexanamine, which was not indicated on the WADA Prohibited List 
2009. However, because of its chemical similarity to the structure of 
tuaminoheptane, it was recognized by the WADA as a substance banned 
in sport [23]. In addition, substances specially designed for doping 
purposes, mainly from the group of anabolic-androgenic steroids, 
continue  to  appear  on  the  market.  The  aim  of  this  study  is   
a warning about the presence of designer steroids in some dietary or 
nutritional supplements. A few doping cases caused by the use of 
supplements with designer steroids, noted by two WADA accredited 
laboratories (Cologne and Warsaw) in recent years, are described. 
MATERIALS AND METHODS 
Gas chromatography-mass spectrometry (GC-MS) analyses were 
performed on an Agilent 6890 Series GC System coupled to an Agilent 
5973 Network Mass Selective Detector with electron ionization (70 eV). 
The column used was an Agilent Ultra-1 (17 m; 0.20 mm i.d.;   
0.1 µm film thickness) using helium as the carrier gas with a constant 
pressure of 1.14 bar. The oven temperature was increased from   
183-232°C by 3°C/min followed by 40°C/min to 310°C and then held 
for 2 min. Samples were injected in split mode (1:16) at 300°C.
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Chemicals and reagents
17β-Hydroxy-17α-methyl  androst-4-en-3-one (methyltestosterone) 
was obtained from Sigma-Aldrich GmbH (Steinheim, Germany) and 
androsta-1,4,6-triene-3,17-dione and 17β-hydroxy  androsta-1,4,6-
trien-3-one from Steraloids (Wilton, USA). 17α-Methyl-5α-androstane-
3α,17β-diol (3α,5α-THMT), 17α-methyl-5β-androstane-3α,17β-diol 
(3α,5β-THMT), 17β-methyl-5α-androstane-3α,17α-diol (3α,5α-
epiTHMT), 17β-methyl-5β-androstane-3α,17α-diol (3α,5β-epiTHMT), 
d3-testosterone,  d3-epitestosterone,  d4-etiocholanolone,  and 
d5-androsterone-glucuronide were synthesized in the Cologne doping 
control laboratory as described by Schänzer et al. [25-27], 17β-hydroxy-
17α-methyl  androsta-4,6-diene-3-one (∆6-methyltestosterone), 
17α-hydroxy-17β-methyl  androsta-4,6-diene-3-one (∆6-epimethyl
testosterone),  3α-hydroxy-6α-methyl-5β-androstan-17-one, 
3α-hydroxy-6α-methylandrost-4-en-17-one, 6α-methyl-testosterone, 
and 3α,17α-dihydroxy-6α-methyl-5β-pregnan-20-one as described 
by Parr et al. [16, 20]. β-Glucuronidase from E. coli was obtained 
from Roche Diagnostics (Mannheim, Germany), N-methyl-N-
trimethylsilyl-trifluoroacetamide (MSTFA) from Chem. Fabrik Karl 
Bucher (Waldstetten, Germany). All other reagents and solvents were 
of analytical grade and were obtained from Merck (Darmstadt, 
Germany).
Urine samples
Urine samples from routine doping control, from two WADA 
accredited laboratories (Cologne and Warsaw), with suspicious 
results in screening for anabolic androgenic steroids were reanalysed 
to trace back the administered substance. Two samples suspicious 
for 17α-methyl-5β-androstane-3α,17β-diol (3α,5β-THMT, samples 
1 and 2), three samples for 17β-hydroxy-5β-androst-1-en-3-one 
(samples 3-5) and two sample with an elevated T/E ratio were 
included in this investigation (samples 6 and 7). The samples were 
handled anonymously following the Declaration of Helsinki.
Sample preparation
The samples were prepared according to the routine steroid screening 
procedure used in the Cologne doping control laboratory [7], in   
the case of samples 1 and 2 without adding 17α-methyltestosterone 
as an internal standard: after addition of the internal standard solution 
(containing d3-testosterone, d3-epitestosterone, d4-etiocholanolone 
and  d5-androsterone-glucuronide  and  for  samples  3-7 
17α-methyltestosterone in addition) 2 mL of urine were incubated at 
pH 7 with β-glucuronidase from E. coli at 50°C for 1 h. The steroids 
were extracted with 5 mL of TBME at pH 9.6 and the organic layer 
was evaporated to dryness. The residues were derivatized with 
trimethyliodosilane (TMIS) reagent (MSTFA/NH4I/ethanethiol, 
1000:2:3, v:w:v) by heating for 20 min at 60°C and 2 µL were injected 
into the GC-MS. In addition to the standard single ion monitoring (SIM) 
procedure, the instrument was also operated in SCAN mode.   
As reference, solutions of the respective steroids in methanol were 
spiked to blank urine and processed in the same manner.
Supplements analysis
In connection with the cases of samples 1 and 2, the sports federation 
collected six dietary supplement products from the athletes. They were 
analysed for the presence of designer steroids by GC-MS in SCAN 
mode after methanolic extraction and derivatization with TMIS reagent.
RESULTS 
The samples initially found suspicious for 3α,5β-THMT (samples 1 
and 2) revealed the presence of four steroids with MS fragments of 
m/z 143. This fragment is recognized as indicative for a 17ξ-methyl-
17ξ-hydroxylated D-ring. The extracted ion chromatogram is given 
in Figure 1. By comparison of the mass spectra and retention times 
of the compounds with those of reference steroids spiked into blank 
urine,  17β-hydroxy-17α-methyl  androsta-4,6-diene-3-one 
(∆6-methyltestosterone), 17α-hydroxy-17β-methyl  androsta-4,6-
FIG. 1. EXTRACTED ION CHROMATOGRAM (m/z 143) OF SAMPLE 1
Time [min]
Abundance
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diene-3-one (∆6-epimethyltestosterone), 17α-methyl-5β-androstane-
3α,17β-diol (3α,5β-THMT), and 17β-methyl-5β-androstane-3α,17α-
diol were identified. Confirmation was performed according to the 
criteria of WADA [33].
The corresponding supplements were tested for designer steroids 
and  one  out  of  the  six  products  was  found  to  contain 
∆6-methyltestosterone. The name of the product label was “Jungle 
Warfare”. The other products did not reveal any steroidal content.
Three samples, initially suspicious for the boldenone metabolite 
17β-hydroxy-5β-androst-1-en-3-one (samples 3-5), were found to 
contain androsta-1,4,6-triene-3,17-dione and 17β-hydroxy-androsta-
1,4,6-trien-3-one as major steroids. Additionally, several minor 
metabolites of androsta-1,4,6-triene-3,17-dione and androst-4-ene-
3,6,17-trione were detected as well. A SCAN chromatogram (TIC) 
of sample 3 is shown in Figure 2.
In sample 6 and 7, initially suspicious due to an elevated T/E ratio, 
four exogenous steroids, namely 3α-hydroxy-6α-methyl-5β-androstan-
17-one, 3α-hydroxy-6α-methylandrost-4-en-17-one, 6α-methyl-
testosterone, and 3α,17α-dihydroxy-6α-methyl-5β-pregnan-20-one, 
were identified besides the altered steroid profile (chromatogram in 
Figure 3).
DISCUSSION 
The reanalysis of samples 1 and 2 resulted in the detection of steroids 
that may be interpreted as metabolites of ∆6-methyltestosterone. 
These findings are consistent with the metabolism reported recently 
by Parr et al. [16]. The availability of the athlete’s supplements 
allowed for confirmation of this interpretation, as one of the products 
indeed contained ∆6-methyltestosterone. These findings confirmed 
the presumption that such products are used by athletes and that 
their consumption may lead to positive results in doping control.
The steroids detected in samples 3-5 most likely trace back to 
administration of androsta-1,4,6-triene-3,17-dione (ATD). This steroid 
is reported to inhibit the enzyme complex aromatase. According to 
our knowledge, no approved pharmaceutical containing ATD is 
available worldwide. However, it was detected as an active ingredient 
in supplements such as Novedex XT, Novedex Xtreme, Arom X, 
Clomed, Estro-Test, Inhibit-E, and ATD [9,17]. In all three urine 
samples, 3α,6α-dihydroxy-5β-androstan-17-one and other metabolites 
indicating co-administration of a 6-oxo-steroid were detected as well. 
Out of the reported ATD products, Novedex XT or Xtreme were   
the only ones that also contained 3-hydroxy-androst-4-ene-6,17-dione 
or 6-hydroxy  androst-4-ene-3,17-dione, respectively. Both compounds 
FIG. 2. SCAN CHROMATOGRAM (TIC) OF SAMPLE 3, TESTED POSITIVE FOR METABOLITES OF ANDROSTA-1,4,6-TRIENE-3,17-DIONE (BLUE ARROWS) 
AND 6-OXOANDROSTENEDIONE (ANDROST-4-ENE-3,6,17-TRIONE, BLACK ARROWS)
FIG. 3. CHROMATOGRAM OF SAMPLE 6, TESTED POSITIVE FOR METABOLITES OF 6α-METHYLANDROST-4-ENE-3,17-DIONE AND 5β-DIHYDROMEDROXY
PROGESTERONE
6α-Methyl- 
androstenedione-M2
5β-Dihydro-
medroxyprogesterone-M  
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may be metabolized to 3α,6α-dihydroxy-5β-androstan-17-one. Thus, 
it is very likely that the athletes in question have administered one 
of these products. 
The findings of metabolites of 6α-methylandrostenedione and 
17α-hydroxy-6α-methyl-5β-pregnane-3,20-dione in samples 6 and 
7 may be conclusive with the administration of a supplement with 
those two steroids as active ingredients. This combination was 
reported for the product “Methyl-1 Pro” [20]. It also contained androst-
4-ene-3,17-dione, which might explain the altered urinary steroid 
profile in the samples.
CONCLUSIONS 
From the cases reported here, it is evident that top level athletes use 
“dietary supplements” that contain so-called designer steroids.   
The statistics of the World Anti-Doping Agency of recent years reported 
some more cases (see Table 1) with steroids that are only available 
in dubious products and not as approved pharmaceuticals. However, 
people outside of elite sport were also found to have used such 
designer supplements. Still more education on the health and doping 
risks of dietary supplement products seems to be necessary for   
the protection of both athletes and the general public.
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